Improved intraportal islet transplantation outcome by systemic IKK-beta inhibition: NF-κB activity in pancreatic islets depends on oxygen availability

C. Chen, R. Moreno, Balaji Samikannu, R. G. Bretzel, M. L. Schmitz, T. Linn

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Intraportal islet transplantation suffers from low efficiency caused by substantial islet mass loss after transplantation. How this process is regulated is still unclear. Here, we show that NF-κB activation was detectable in islet grafts shortly after transplantation of porcine islets to diabetic NMRI nu/nu mice, and systemic NF-κB inhibition in transplanted animals significantly prolonged islet graft survival. Proinflammatory cytokines alone did not cause evident cell death in pancreatic islet within 24 h, while the combination of cytokines with hypoxia resulted in a strong induction of cell death that could be blocked dose-dependently by a selective IKK-β inhibitor. Under hypoxia, NF-κB activity impaired expression of antiapoptotic gene BCL-xL, c-FLIP and survivin. NF-κB activation in isolated islets was reduced by hypoxia in a time-dependent manner, accordingly, NF-κB activation in transplanted islets diminished by time. Our data indicate that, while NF-κB has an antiapoptotic role under normoxia, low oxygen conditions decrease its activity and transform it to a proapoptotic transcription factor in pancreatic islets. We conclude that NF-κB inhibition represents a potential strategy to improve islet transplantation efficiency.

Original languageEnglish
Pages (from-to)215-224
Number of pages10
JournalAmerican Journal of Transplantation
Volume11
Issue number2
DOIs
Publication statusPublished - 1 Feb 2011
Externally publishedYes

    Fingerprint

Keywords

  • engraftment
  • hypoxia
  • innate immunity
  • Islet transplantation
  • NF-kappaB
  • transplantation efficiency

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)

Cite this